rs1051730
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1
The NM_000743.5(CHRNA3):c.645C>T(p.Tyr215Tyr) variant causes a synonymous change. The variant allele was found at a frequency of 0.305 in 1,613,104 control chromosomes in the GnomAD database, including 80,492 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.26 ( 6058 hom., cov: 31)
Exomes 𝑓: 0.31 ( 74434 hom. )
Consequence
CHRNA3
NM_000743.5 synonymous
NM_000743.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 5.50
Publications
577 publications found
Genes affected
CHRNA3 (HGNC:1957): (cholinergic receptor nicotinic alpha 3 subunit) This locus encodes a member of the nicotinic acetylcholine receptor family of proteins. Members of this family of proteins form pentameric complexes comprised of both alpha and beta subunits. This locus encodes an alpha-type subunit, as it contains characteristic adjacent cysteine residues. The encoded protein is a ligand-gated ion channel that likely plays a role in neurotransmission. Polymorphisms in this gene have been associated with an increased risk of smoking initiation and an increased susceptibility to lung cancer. Alternatively spliced transcript variants have been described. [provided by RefSeq, Nov 2009]
CHRNA3 Gene-Disease associations (from GenCC):
- urinary bladder, atony ofInheritance: AR Classification: STRONG Submitted by: Ambry Genetics, G2P
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.48).
BP6
Variant 15-78601997-G-A is Benign according to our data. Variant chr15-78601997-G-A is described in ClinVar as Benign. ClinVar VariationId is 17503.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.344 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CHRNA3 | NM_000743.5 | c.645C>T | p.Tyr215Tyr | synonymous_variant | Exon 5 of 6 | ENST00000326828.6 | NP_000734.2 | |
| CHRNA3 | NM_001166694.2 | c.645C>T | p.Tyr215Tyr | synonymous_variant | Exon 5 of 6 | NP_001160166.1 | ||
| CHRNA3 | XM_006720382.4 | c.444C>T | p.Tyr148Tyr | synonymous_variant | Exon 5 of 6 | XP_006720445.1 | ||
| CHRNA3 | NR_046313.2 | n.847C>T | non_coding_transcript_exon_variant | Exon 5 of 8 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CHRNA3 | ENST00000326828.6 | c.645C>T | p.Tyr215Tyr | synonymous_variant | Exon 5 of 6 | 1 | NM_000743.5 | ENSP00000315602.5 | ||
| CHRNA3 | ENST00000348639.7 | c.645C>T | p.Tyr215Tyr | synonymous_variant | Exon 5 of 6 | 1 | ENSP00000267951.4 | |||
| CHRNA3 | ENST00000558903.1 | n.352C>T | non_coding_transcript_exon_variant | Exon 2 of 2 | 4 | |||||
| CHRNA3 | ENST00000559658.5 | n.645C>T | non_coding_transcript_exon_variant | Exon 5 of 8 | 2 | ENSP00000452896.1 |
Frequencies
GnomAD3 genomes AF: 0.258 AC: 39177AN: 151744Hom.: 6060 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
39177
AN:
151744
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.269 AC: 67652AN: 251254 AF XY: 0.279 show subpopulations
GnomAD2 exomes
AF:
AC:
67652
AN:
251254
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.310 AC: 453238AN: 1461244Hom.: 74434 Cov.: 42 AF XY: 0.310 AC XY: 225164AN XY: 726806 show subpopulations
GnomAD4 exome
AF:
AC:
453238
AN:
1461244
Hom.:
Cov.:
42
AF XY:
AC XY:
225164
AN XY:
726806
show subpopulations
African (AFR)
AF:
AC:
3682
AN:
33468
American (AMR)
AF:
AC:
7865
AN:
44710
Ashkenazi Jewish (ASJ)
AF:
AC:
9979
AN:
26132
East Asian (EAS)
AF:
AC:
1050
AN:
39680
South Asian (SAS)
AF:
AC:
20578
AN:
86240
European-Finnish (FIN)
AF:
AC:
17619
AN:
53410
Middle Eastern (MID)
AF:
AC:
2173
AN:
5768
European-Non Finnish (NFE)
AF:
AC:
372463
AN:
1111468
Other (OTH)
AF:
AC:
17829
AN:
60368
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
19909
39818
59726
79635
99544
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
11566
23132
34698
46264
57830
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.258 AC: 39187AN: 151860Hom.: 6058 Cov.: 31 AF XY: 0.254 AC XY: 18879AN XY: 74220 show subpopulations
GnomAD4 genome
AF:
AC:
39187
AN:
151860
Hom.:
Cov.:
31
AF XY:
AC XY:
18879
AN XY:
74220
show subpopulations
African (AFR)
AF:
AC:
4902
AN:
41432
American (AMR)
AF:
AC:
3566
AN:
15252
Ashkenazi Jewish (ASJ)
AF:
AC:
1318
AN:
3468
East Asian (EAS)
AF:
AC:
167
AN:
5168
South Asian (SAS)
AF:
AC:
1057
AN:
4798
European-Finnish (FIN)
AF:
AC:
3431
AN:
10526
Middle Eastern (MID)
AF:
AC:
121
AN:
294
European-Non Finnish (NFE)
AF:
AC:
23626
AN:
67902
Other (OTH)
AF:
AC:
617
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1375
2751
4126
5502
6877
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
392
784
1176
1568
1960
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
412
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1Other:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Lung cancer susceptibility 2 Other:1
May 01, 2008
OMIM
Significance:risk factor
Review Status:no assertion criteria provided
Collection Method:literature only
- -
SMOKING AS A QUANTITATIVE TRAIT LOCUS 3 Other:1
May 01, 2008
OMIM
Significance:risk factor
Review Status:no assertion criteria provided
Collection Method:literature only
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.